Gemicine(SRL)

BE 0758.504.663

	2024		2023		2022
Profit/Loss Section 9904: Profit/Loss of the financial year (after taxes on result) (+/-)	€ -5.544	-353%	€ 2.191	-10%	€ 2.436
Equity Section 10/15: Equity consists of capital, capital reserves and earnings that remain within the company. These are fully owned by the company and are at its disposal to cover its risks. The better the ratio between equity and debts, the more solvent a company is. A positive equity ratio is important. A negative equity ratio (because of accumulated losses) is a severe warning sign that the continuity of the company may be threatened.	€ 49.084	-10%	€ 54.628	4%	€ 52.436
Gross margin Section 9900: Gross margin or added value is net sales minus the direct costs of the goods sold. In other words: sales invoices minus purchase invoices (70/74 – 60/61). A negative gross margin is a warning sign especially when occurring over several years. It may indicate that the company has insufficient means to cover internal costs like salaries, etc.	€ -4.520	-223%	€ 3.661	-14%	€ 4.249

	Date	Publication
	28-12-2023	Resignations - Appointments (NL)
	19-11-2020	Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

What is the VAT number of Gemicine?

The VAT number of Gemicine is BE0758504663.

When was Gemicine founded?

Gemicine was founded on 17-11-2020.

What is the address of Gemicine?

The current registered office of Gemicine is located at Kerkplein 8, 2950 Kapellen.

When was the last time Gemicine filed their annual financial statements?

The most recent financial statements of Gemicine were filed on 29-10-2024. You can view them here.

How many employees does Gemicine have?

There are currently no employees working at Gemicine or no workforce information is available.

What is the annual turnover of Gemicine?

At the time of its most recent financial statements, Gemicine did not publish any turnover figures. Gemicine reported a gross margin of -€4,520.00.